Monoclonal antibody therapy of T cell lymphoma: single agent trials of anti-CD2 (Siplizumab) and anti-CD4 (Humax-CD4). Hematol Meeting Rep [Internet]. 2009 Jun. 11 [cited 2026 Jun. 2];3(1). Available from: https://journals.pagepress.net/hmr/article/view/532